42860-33-3 Usage
General Description
2,3,5-Triiodo-benzoyl chloride is a chemical compound with the molecular formula C7H2ClI3O. It is an organoiodine compound that is commonly used in organic synthesis and as a reagent in the pharmaceutical industry. The compound is a yellowish solid that is highly reactive and can be hazardous if not handled properly. It is a versatile compound in organic chemistry, as it can be used in the synthesis of various pharmaceuticals, agrochemicals, and dyes. Additionally, it is also used as a building block for the preparation of other organic compounds. Due to its reactive nature and potential hazards, it should be handled and stored with caution and in accordance with proper safety protocols.
Check Digit Verification of cas no
The CAS Registry Mumber 42860-33-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,2,8,6 and 0 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 42860-33:
(7*4)+(6*2)+(5*8)+(4*6)+(3*0)+(2*3)+(1*3)=113
113 % 10 = 3
So 42860-33-3 is a valid CAS Registry Number.
InChI:InChI=1/C7H2ClI3O/c8-7(12)4-1-3(9)2-5(10)6(4)11/h1-2H
42860-33-3Relevant articles and documents
ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING METHOD
-
Paragraph 0224-0225, (2021/06/21)
PROBLEM TO BE SOLVED: To provide a chemically amplified resist composition that has high sensitivity in photolithography using, as a light source, high energy rays such as KrF excimer laser light, ArF excimer laser light, electron beams, extreme ultraviol
IODINE-CONTAINING PHOTOACID GENERATORS AND COMPOSITIONS COMPRISING THE SAME
-
Paragraph 0113, (2019/06/07)
A photoacid generator compound having formula (I): wherein, in formula (I), groups and variables are the same as described in the specification.
Radiopaque poly(ε-caprolactone) as additive for X-ray imaging of temporary implantable medical devices
Samuel, Rémi,Girard, Edouard,Chagnon, Grégory,Dejean, Stéphane,Favier, Denis,Coudane, Jean,Nottelet, Benjamin
, p. 84125 - 84133 (2015/10/28)
Implantable polymeric medical devices suffer from a lack of visibility under current clinical imaging techniques. To circumvent this problem, poly(ε-caprolactone-co-α-triiodobenzoate-ε-caprolactone)s (PCL-TIB) containing from 3.5% to 24% of triiodobenzoat
